Incyte news in 2026: 12 dated events
The latest Incyte event on this page is dated Sep 26, 2026. tipranks.com reported: Mirum Pharmaceuticals, Incyte announce FDA approval of Atebrioz.
Public (INCY)Pharmaceutical Manufacturing5,001 to 10,000 employeesincyte.comLinkedIn
- Dated events
- 12
- Last 90 days
- 3
- Latest
- Sep 26, 2026
News · latest 10
Latest Incyte news
Showing 10 of 12 dated events. The Signal API returns all of them.
Get them with one API call- Mirum Pharmaceuticals, Incyte announce FDA approval of AtebriozIncyte, in collaboration with Mirum Pharmaceuticals, received FDA approval for its Atebrioz tablets, a treatment for fibrodysplasia ossificans progressiva in patients aged 12 and older.
- Incyte stock reports 38 percent revenue growth as shares trade at USD 123.47Incyte reported Q2 2026 revenue of USD 1.67 billion, a 38% increase year-over-year.
- A Noteworthy Decision By Lee Heeson As Acquires $130K In Incyte Stock OptionsIncyte reported a gross margin of 91.79% and an EPS of 1.52.
- Incyte expands haematology portfolio with vega acquisition.With VEGA Americas, Inc.
- Incyte's stars align as new CEO strikes $2B Vega takeover for blood disorder asset.$2B · With Vega Therapeutics, Inc.
- Incyte nears up to $2 billion deal for blood disorder biotech Star, FT reports.$2B · With Star Therapeutics, Inc.
- PharmaEssentia appoints Eric Vogel as U.S. Head of Commercialization ahead of potential launch of BESREMi(R) in essential thrombocythemia.Vogel, Group Vice President of Sales and Marketing
- Incyte partners with Edison Scientific to integrate AI across drug discovery and translational research.With Edison Scientific Inc.
- Incyte Corp stock (US45337C1027): Biopharma leader in oncology therapies.Incyte Corporation is developing novel therapies in oncology and inflammation.
- Incyte appoints Suketu (Suky) Upadhyay as Chief Financial Officer.Suketu (Suky) Upadhyay, Chief Financial Officer
Showing 10 of 12 dated events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Incyte with the Signal API
One POST /v1/companies/enrich call with incyte.com returns Incyte news signals (news), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"incyte.com","signal_types":["news"],"limit":20}'Same industry
News at related companies
Questions about Incyte news
What is the latest news on Incyte?
What is going on with Incyte?
Source. News articles about the company, one source link per event.
Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.
Data as of .